ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ASTRAZENECA PLC ADRhedged
53.28
0.0000
成交量:
- -
成交額:
- -
市值:
159.83萬
市盈率:
- -
高:
53.28
開:
53.28
低:
53.28
收:
53.28
52周最高:
56.90
52周最低:
40.24
股本:
3.00萬
流通股本:
1.00萬
量比:
2.68
換手率:
- -
股息:
0.58
股息率:
1.08%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
多家藥企高管生變:恒瑞、復星、阿斯利康、輝瑞…
赛柏蓝
·
05/07
伯恩斯坦將阿斯利康目標價從20500便士下調至18600便士。
智通财经
·
05/01
美國監管委員會投票否決乳腺癌藥物後,阿斯利康股價下跌
路透中文
·
05/01
阿斯利康乳腺癌候選藥物未獲FDA諮詢委員會投票通過
环球市场播报
·
05/01
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AZNH"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1778270400000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"05-08 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1778486400000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":2.6812474453400963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.6812474453400963,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":40.235,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633794147","title":"多家藥企高管生變:恒瑞、復星、阿斯利康、輝瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633794147?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日,恒瑞医药发布公告,正式完成新一届董事会和管理层聘任。复星医药4月2日,复星医药发布首席财务官变更公告,因工作安排调整,陈战宇辞去首席财务官职务。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["AZNH","LU1829250122.USD","BK4588","LU1023059063.AUD","LU1883839398.USD","688235","LU0868494617.USD","BK4550","LU0985481810.HKD","LU1894683264.USD","LU1057294990.SGD","LU2237443549.SGD","SG9999002232.USD","BK4007","LU0058720904.USD","LU0306807586.USD","LU0889565916.HKD","SG9999001176.USD","LU0289739699.SGD","ONC","SG9999013999.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU2417539215.USD","BK4599","600196","BK4585","BK4592","LU0320765992.SGD","PFE","BK4533","600276","LU2462157665.USD","LU2237443465.HKD","AZN","LU0321505868.SGD","SG9999002224.SGD","LU0109394709.USD","LU0170899867.USD","LU0225771236.USD","LU0456855351.SGD","LU1894683348.USD","BK4534","LU1066051498.USD","IE00BLSP4239.USD","LU0306806265.USD","LU2456880835.USD","BK4568","LU0234572021.USD","LU2237443978.SGD","SG9999003800.SGD","LU0225284248.USD","IE00BLSP4452.SGD","LU1066053197.SGD","02142","LU2237443382.USD","IE00B3T34201.USD","BK4581","LU2237443622.USD","LU2237443895.HKD","IE00B19Z3581.USD","LU0122379950.USD","01276","LU0321505439.SGD","SG9999001176.SGD","IE0002270589.USD","02196","IE000M9KFDE8.USD","SG9999011175.SGD","06160","IE00BBT3K403.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632619163","title":"伯恩斯坦將阿斯利康目標價從20500便士下調至18600便士。","url":"https://stock-news.laohu8.com/highlight/detail?id=2632619163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632619163?lang=zh_tw&edition=fundamental","pubTime":"2026-05-01 19:09","pubTimestamp":1777633776,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AZN.UK","AZN","AZNH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632618147","title":"美國監管委員會投票否決乳腺癌藥物後,阿斯利康股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2632618147","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632618147?lang=zh_tw&edition=fundamental","pubTime":"2026-05-01 16:31","pubTimestamp":1777624295,"startTime":"0","endTime":"0","summary":"更新 2-美国监管委员会投票否决乳腺癌药物后,阿斯利康股价下跌专家小组以试验设计存在问题为由,投票反对卡米泽特兰分析师称卡米泽特兰仍有获批可能ODAC支持阿斯利康的Truqap用于治疗转移性前列腺癌股价下跌1.9%在第3段补充Truqap的投票结果,第6和8段补充分析师评论,第7和9段补充阿斯利康的业绩目标及股价详情","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL4S41E0B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0499090636.EUR","LU0553294199.USD","LU2357627491.SGD","LU2023251221.USD","AZN","LU2355687059.USD","LU2112291526.USD","LU0882574055.USD","LU1023059063.AUD","LU0058720904.USD","AZNH","LU0203347892.USD","IE0034235188.USD","LU2133065610.SGD","LU1989772923.USD","IE0009355771.USD","LU2433249047.HKD","LU2089984988.USD","LU1267930227.SGD","LU1989772840.SGD","LU1051770623.HKD","LU1153584641.USD","LU1046234339.USD","LU0047473722.SGD","LU0128525689.USD","LU1003077747.HKD","LU1019634622.SGD","LU1267930490.SGD","LU2324357040.USD","SG9999001176.SGD","AZN.UK","LU1084165304.USD","LU1061106388.HKD","LU1196032939.SGD","LU1481600234.SGD","IE00BJT1NW94.SGD","LU0859254822.USD","LU1496350171.SGD","LU1019632923.USD","LU0823416689.USD","LU0203345920.USD","IE00B2B36J28.USD","LU2125909593.SGD","LU0289739699.SGD","LU0211327993.USD","LU2468319806.SGD","LU1104425308.USD","SG9999001176.USD","LU0122379950.USD","LU0432979614.USD","LU0640478417.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632504618","title":"阿斯利康乳腺癌候選藥物未獲FDA諮詢委員會投票通過","url":"https://stock-news.laohu8.com/highlight/detail?id=2632504618","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632504618?lang=zh_tw&edition=fundamental","pubTime":"2026-05-01 16:14","pubTimestamp":1777623240,"startTime":"0","endTime":"0","summary":"在乳腺癌候选药物未能在一项关键的咨询委员会投票中获得支持后,英国制药集团阿斯利康表示,该公司将继续与美国监管机构合作,对该药物进行审查。该公司周四晚间表示,美国食品药品管理局的肿瘤药物咨询委员会以6比3的投票结果,对乳腺癌治疗候选药物camizestrant的获益-风险评估给出否定性意见。阿斯利康的股价在周五开盘交易中下跌了约1.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-01/doc-inhwktza5459710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B3T34201.USD","LU0889565916.HKD","LU0058720904.USD","LU2417539215.USD","BK4568","LU2237443895.HKD","BK4585","LU0320765992.SGD","LU2237443978.SGD","BK4007","AZN.UK","AZNH","LU1829250122.USD","BK4588","LU2237443549.SGD","LU2462157665.USD","LU2237443465.HKD","AZN","LU2237443622.USD","LU0109394709.USD","LU2456880835.USD","LU2236285917.USD","LU0289739699.SGD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AZNH\",params:#limit:6,delay:false,,,undefined,":[]}}